The Value of Pediatricians on Pharmacy and Therapeutics Committees.
作者信息
Austin Jared P, Gunden Sara, Hoffner Wendy, Ismail Lana, Mendez Suzanne, Alvarez Francisco
出版信息
P T. 2019 Jan;44(1):2-4.
Abstract
摘要
相似文献
1
The Value of Pediatricians on Pharmacy and Therapeutics Committees.
P T. 2019 Jan;44(1):2-4.
2
Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
Am J Health Syst Pharm. 1999 Apr 1;56(7):622-8. doi: 10.1093/ajhp/56.7.622.
3
A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
Can J Clin Pharmacol. 2009 Winter;16(1):e171-7. Epub 2009 Feb 25.
4
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
Drug Saf. 1998 Mar;18(3):153-9. doi: 10.2165/00002018-199818030-00001.
5
[Pharmacy and therapeutics committees in Brazil: lagging behind international standards].
Rev Panam Salud Publica. 2006 Jan;19(1):58-63. doi: 10.1590/s1020-49892006000100014.
6
Pharmacist and Pediatrician Knowledge of Codeine Use in Children.
J Pediatr Pharmacol Ther. 2018 Jul-Aug;23(4):293-297. doi: 10.5863/1551-6776-23.4.293.
7
Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
Clin Ther. 1993 Mar-Apr;15(2):433-41; discussion 432.
8
ASHP national survey of pharmacy practice in acute care settings: prescribing and transcribing--1998. American Society of Health-System Pharmacists.
Am J Health Syst Pharm. 1999 Jan 15;56(2):142-57. doi: 10.1093/ajhp/56.2.142.
9
Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
Am J Health Syst Pharm. 2019 Apr 8;76(8):537-542. doi: 10.1093/ajhp/zxz022.
10
Improving pharmacy and therapeutics committee operations.
Am J Hosp Pharm. 1984 Sep;41(9):1767-77.
本文引用的文献
1
Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System.
Am Health Drug Benefits. 2018 Apr;11(2):65-73.
2
Controlling postoperative use of i.v. acetaminophen at an academic medical center.
Am J Health Syst Pharm. 2018 Apr 15;75(8):548-555. doi: 10.2146/ajhp170054. Epub 2018 Feb 21.
3
Use of Intranasal Dexmedetomidine as a Solo Sedative for MRI of Infants.
Hosp Pediatr. 2018 Jan 23. doi: 10.1542/hpeds.2017-0120.
4
Eteplirsen in the treatment of Duchenne muscular dystrophy.
Drug Des Devel Ther. 2017 Feb 28;11:533-545. doi: 10.2147/DDDT.S97635. eCollection 2017.
5
Pediatric Medication Safety in Adult Community Hospital Settings: A Glimpse Into Nationwide Practice.
Hosp Pediatr. 2016 Dec;6(12):744-749. doi: 10.1542/hpeds.2016-0068. Epub 2016 Nov 3.
6
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Ann Neurol. 2016 Feb;79(2):257-71. doi: 10.1002/ana.24555. Epub 2016 Jan 8.
7
Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making.
Can J Hosp Pharm. 2015 May-Jun;68(3):238-47. doi: 10.4212/cjhp.v68i3.1458.
8
Pediatric medication error reports in Korea adverse event reporting system database, 1989-2012: comparing with adult reports.
J Korean Med Sci. 2015 Apr;30(4):371-7. doi: 10.3346/jkms.2015.30.4.371. Epub 2015 Mar 19.
9
The changing roles of p&t committees: a look back at the last decade and a look forward to 2020.
P T. 2014 Nov;39(11):760-72.
10
Eteplirsen for the treatment of Duchenne muscular dystrophy.
Ann Neurol. 2013 Nov;74(5):637-47. doi: 10.1002/ana.23982. Epub 2013 Sep 10.
Zotero 插件